Radioimmunotherapy of Non-Hodgkin’s Lymphoma
2004
TO THE EDITOR:
The contrast between 2 papers on this topic published side by side in The Journal of Nuclear Medicine is quite striking. The first, by Koral et al. ([1][1]), concentrates on tumor dosimetry and response using 131I-tositumomab therapy. The second, by Wiseman et al. ([2][2]) on
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
47
References
20
Citations
NaN
KQI